O-0022 * RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF TAS-102 VS. PLACEBO, WITH BEST SUPPORTIVE CARE (BSC), IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) REFRACTORY TO STANDARD THERAPIES (RECOURSE)

✍ Scribed by Yoshino, T.; Mayer, R.; Falcone, A.; Ohtsu, A.; Garcia-Carbonero, R.; Mizunuma, N.; Yamazaki, K.; Shimada, Y.; Tabernero, J.; Komatsu, Y.; Sobrero, A.; Boucher, E.; Peeters, M.; Tran, B.; Lenz, H. J.; Zaniboni, A.; Hochster, H.; Benedetti, F.; Aivado, M.; Makris, L.; Ito, M.; Van Cutsem, E.

• Book ID: 125497738
• Publisher: Oxford University Press
• Year: 2014
• Tongue: English
• Weight: 34 KB
• Volume: 25
• Category: Article
• ISSN: 0923-7534
• DOI: 10.1093/annonc/mdu193.22